4.35
price down icon2.24%   -0.11
 
loading

Lantern Pharma Inc Azioni (LTRN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
19.03%
4.774
5.8964 5.1796 5.4085 5.732
Depreciation and Amortization
0.00%
0.00457
0.00457 - - -
Operating Income/Loss
19.03%
-4.774
-5.8964 -5.1796 -5.4085 -5.732
Income/Loss From Continuing Operations Before Tax
22.78%
-4.5368
-5.8752 -4.5057 -4.9595 -5.4408
Income/Loss From Continuing Operations After Tax
22.78%
-4.5368
-5.8752 -4.5057 -4.9595 -5.4408
Net Income/Loss
22.78%
-4.5368
-5.8752 -4.5057 -4.9595 -5.4408
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
147.56K%
10.78
0.0073 10.76 10.76 10.74
Diluted Average Shares
147.56K%
10.78
0.0073 10.76 10.76 10.74
Basic Earnings Per Share
22.22%
-0.42
-0.54 -0.42 -0.46 -0.51
Diluted Earnings Per Share
22.22%
-0.42
-0.54 -0.42 -0.46 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.58
price up icon 1.60%
$85.81
price up icon 0.43%
$25.35
price down icon 0.12%
$111.72
price up icon 0.25%
$129.44
price up icon 1.89%
biotechnology ONC
$309.38
price down icon 1.14%
Capitalizzazione:     |  Volume (24 ore):